Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of Lutong capsule for preventive treatment of migraine
CTR20220907Phase 2Completed
- Sponsor
- Green Valley
- Start
- Sep 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in migraine comparing Lutong capsule with Placebo (2 arms). Primary endpoint: Change in migraine days during treatment weeks 9 to 12 versus baseline. Started Sep 2022; status: completed.
02
Drugs
Lutong Capsule
03
Conditions
migraine
Beyond the preview
Go deeper on CTR20220907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220907.